0001493152-24-008818.txt : 20240305
0001493152-24-008818.hdr.sgml : 20240305
20240305103332
ACCESSION NUMBER: 0001493152-24-008818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bentovim Lyron L
CENTRAL INDEX KEY: 0001326879
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40556
FILM NUMBER: 24718683
MAIL ADDRESS:
STREET 1: 60 CUTTER MILL ROAD
STREET 2: GREAT NECK
CITY: NEW YORK
STATE: NY
ZIP: 11021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Glimpse Group, Inc.
CENTRAL INDEX KEY: 0001854445
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 812958271
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 15 WEST 38TH ST, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-292-2685
MAIL ADDRESS:
STREET 1: 15 WEST 38TH ST, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
4
1
ownership.xml
X0508
4
2024-02-29
0
0001854445
Glimpse Group, Inc.
VRAR
0001326879
Bentovim Lyron L
15 WEST 38TH ST, 12TH FLOOR
NEW YORK
NY
10018
1
1
0
0
President and CEO
0
Stock Option (Right to Purchase)
2024-02-29
2024-02-29
4
D
0
90188
0
D
Common Stock
90188
0
D
Stock Option (Right to Purchase)
2024-03-01
2024-03-01
4
A
0
72153
0
A
2031-03-01
Common Stock
72153
1282153
D
Represents the forfeiture of fully vested options to purchase an aggregate of 90,188 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 32,508 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (ii) 6,037 shares of common stock and 4,799 shares of common stock granted on September 1, 2019 with an exercise price of $4.00/share, (iii) 22,222 shares of common stock and 6,674 shares of common stock granted on January 1, 2020 with an exercise price of $4.50/share, (iv) 2,333 shares of common stock granted on May 1, 2020 with an exercise price of $4.50/share, (v) 1,167 shares of common stock granted on July 1, 2020 with an exercise price of $4.50/share, and (vi) 14,448 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share.
The options in footnote (1) were to expire 10 years from their respective grant dates.
Mr. Bentovim was granted options to purchase an aggregate of 72,153 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 24,051 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.
/s/ Lyron L. Bentovim
2024-03-05